Industrial - Machinery
Compare Stocks
3 / 10Stock Comparison
EMR vs HON vs ROK
Revenue, margins, valuation, and 5-year total return — side by side.
Conglomerates
Industrial - Machinery
EMR vs HON vs ROK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | Industrial - Machinery | Conglomerates | Industrial - Machinery |
| Market Cap | $83.18B | $137.39B | $51.65B |
| Revenue (TTM) | $18.32B | $36.76B | $8.80B |
| Net Income (TTM) | $2.44B | $4.10B | $1.09B |
| Gross Margin | 39.4% | 36.9% | 52.5% |
| Operating Margin | 19.4% | 14.9% | 19.1% |
| Forward P/E | 22.8x | 20.6x | 37.8x |
| Total Debt | $13.76B | $34.58B | $3.65B |
| Cash & Equiv. | $1.54B | $12.49B | $468M |
EMR vs HON vs ROK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Emerson Electric Co. (EMR) | 100 | 242.4 | +142.4% |
| Honeywell Internati… (HON) | 100 | 148.7 | +48.7% |
| Rockwell Automation… (ROK) | 100 | 212.5 | +112.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EMR vs HON vs ROK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EMR is the clearest fit if your priority is growth exposure and valuation efficiency.
- Rev growth 3.0%, EPS growth 17.8%, 3Y rev CAGR 9.3%
- PEG 5.04 vs HON's 11.22
- 13.3% margin vs HON's 11.2%
HON carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 15 yrs, beta 0.74, yield 2.1%
- Lower volatility, beta 0.74, current ratio 1.32x
- Beta 0.74, yield 2.1%, current ratio 1.32x
ROK is the clearest fit if your priority is long-term compounding.
- 347.3% 10Y total return vs EMR's 215.5%
- +83.7% vs HON's +5.5%
- 9.7% ROA vs HON's 5.3%, ROIC 15.1% vs 12.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.8% revenue growth vs ROK's 1.0% | |
| Value | Lower P/E (20.6x vs 37.8x) | |
| Quality / Margins | 13.3% margin vs HON's 11.2% | |
| Stability / Safety | Beta 0.74 vs EMR's 1.52 | |
| Dividends | 2.1% yield, 15-year raise streak, vs EMR's 1.4% | |
| Momentum (1Y) | +83.7% vs HON's +5.5% | |
| Efficiency (ROA) | 9.7% ROA vs HON's 5.3%, ROIC 15.1% vs 12.6% |
EMR vs HON vs ROK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
EMR vs HON vs ROK — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — EMR and ROK each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HON is the larger business by revenue, generating $36.8B annually — 4.2x ROK's $8.8B. Profitability is closely matched — net margins range from 13.3% (EMR) to 11.2% (HON). On growth, ROK holds the edge at +11.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $18.3B | $36.8B | $8.8B |
| EBITDAEarnings before interest/tax | $4.7B | $6.5B | $1.9B |
| Net IncomeAfter-tax profit | $2.4B | $4.1B | $1.1B |
| Free Cash FlowCash after capex | $3.1B | $4.2B | $1.3B |
| Gross MarginGross profit ÷ Revenue | +39.4% | +36.9% | +52.5% |
| Operating MarginEBIT ÷ Revenue | +19.4% | +14.9% | +19.1% |
| Net MarginNet income ÷ Revenue | +13.3% | +11.2% | +12.4% |
| FCF MarginFCF ÷ Revenue | +17.0% | +11.4% | +15.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.9% | -6.9% | +11.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +28.2% | -41.9% | +39.6% |
Valuation Metrics
HON leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 29.5x trailing earnings, HON trades at a 51% valuation discount to ROK's 59.9x P/E. Adjusting for growth (PEG ratio), EMR offers better value at 8.11x vs HON's 16.04x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $83.2B | $137.4B | $51.6B |
| Enterprise ValueMkt cap + debt − cash | $95.4B | $159.5B | $54.8B |
| Trailing P/EPrice ÷ TTM EPS | 36.61x | 29.46x | 59.89x |
| Forward P/EPrice ÷ next-FY EPS est. | 22.77x | 20.60x | 37.84x |
| PEG RatioP/E ÷ EPS growth rate | 8.11x | 16.04x | — |
| EV / EBITDAEnterprise value multiple | 18.89x | 20.05x | 31.36x |
| Price / SalesMarket cap ÷ Revenue | 4.62x | 3.67x | 6.19x |
| Price / BookPrice ÷ Book value/share | 4.13x | 9.03x | 14.00x |
| Price / FCFMarket cap ÷ FCF | 31.19x | 25.48x | 38.03x |
Profitability & Efficiency
ROK leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
ROK delivers a 29.6% return on equity — every $100 of shareholder capital generates $30 in annual profit, vs $12 for EMR. EMR carries lower financial leverage with a 0.68x debt-to-equity ratio, signaling a more conservative balance sheet compared to HON's 2.24x. On the Piotroski fundamental quality scale (0–9), ROK scores 8/9 vs HON's 6/9, reflecting strong financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | +12.1% | +23.1% | +29.6% |
| ROA (TTM)Return on assets | +5.8% | +5.3% | +9.7% |
| ROICReturn on invested capital | +8.2% | +12.6% | +15.1% |
| ROCEReturn on capital employed | +10.0% | +12.6% | +18.5% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 6 | 8 |
| Debt / EquityFinancial leverage | 0.68x | 2.24x | 0.98x |
| Net DebtTotal debt minus cash | $12.2B | $22.1B | $3.2B |
| Cash & Equiv.Liquid assets | $1.5B | $12.5B | $468M |
| Total DebtShort + long-term debt | $13.8B | $34.6B | $3.6B |
| Interest CoverageEBIT ÷ Interest expense | 6.61x | 3.92x | 9.06x |
Total Returns (Dividends Reinvested)
ROK leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ROK five years ago would be worth $18,015 today (with dividends reinvested), compared to $10,364 for HON. Over the past 12 months, ROK leads with a +83.7% total return vs HON's +5.5%. The 3-year compound annual growth rate (CAGR) favors EMR at 22.6% vs HON's 5.2% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | +9.3% | +11.3% | +15.6% |
| 1-Year ReturnPast 12 months | +39.9% | +5.5% | +83.7% |
| 3-Year ReturnCumulative with dividends | +84.1% | +16.6% | +68.9% |
| 5-Year ReturnCumulative with dividends | +69.0% | +3.6% | +80.1% |
| 10-Year ReturnCumulative with dividends | +215.5% | +134.6% | +347.3% |
| CAGR (3Y)Annualised 3-year return | +22.6% | +5.2% | +19.1% |
Risk & Volatility
Evenly matched — HON and ROK each lead in 1 of 2 comparable metrics.
Risk & Volatility
HON is the less volatile stock with a 0.74 beta — it tends to amplify market swings less than EMR's 1.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ROK currently trades 99.1% from its 52-week high vs HON's 87.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.52x | 0.74x | 1.33x |
| 52-Week HighHighest price in past year | $165.15 | $248.18 | $463.49 |
| 52-Week LowLowest price in past year | $106.53 | $186.76 | $250.32 |
| % of 52W HighCurrent price vs 52-week peak | +89.6% | +87.4% | +99.1% |
| RSI (14)Momentum oscillator 0–100 | 48.4 | 32.3 | 68.9 |
| Avg Volume (50D)Average daily shares traded | 2.8M | 3.7M | 836K |
Analyst Outlook
Evenly matched — EMR and HON each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: EMR as "Buy", HON as "Buy", ROK as "Hold". Consensus price targets imply 12.5% upside for HON (target: $244) vs -5.0% for ROK (target: $437). For income investors, HON offers the higher dividend yield at 2.14% vs ROK's 1.14%.
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $161.92 | $243.83 | $436.56 |
| # AnalystsCovering analysts | 41 | 28 | 39 |
| Dividend YieldAnnual dividend ÷ price | +1.4% | +2.1% | +1.1% |
| Dividend StreakConsecutive years of raises | 37 | 15 | 20 |
| Dividend / ShareAnnual DPS | $2.10 | $4.63 | $5.23 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.5% | +2.8% | +0.8% |
ROK leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). HON leads in 1 (Valuation Metrics). 3 tied.
EMR vs HON vs ROK: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is EMR or HON or ROK a better buy right now?
For growth investors, Honeywell International Inc.
(HON) is the stronger pick with 7. 8% revenue growth year-over-year, versus 1. 0% for Rockwell Automation, Inc. (ROK). Honeywell International Inc. (HON) offers the better valuation at 29. 5x trailing P/E (20. 6x forward), making it the more compelling value choice. Analysts rate Emerson Electric Co. (EMR) a "Buy" — based on 41 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EMR or HON or ROK?
On trailing P/E, Honeywell International Inc.
(HON) is the cheapest at 29. 5x versus Rockwell Automation, Inc. at 59. 9x. On forward P/E, Honeywell International Inc. is actually cheaper at 20. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Emerson Electric Co. wins at 5. 04x versus Honeywell International Inc. 's 11. 22x.
03Which is the better long-term investment — EMR or HON or ROK?
Over the past 5 years, Rockwell Automation, Inc.
(ROK) delivered a total return of +80. 1%, compared to +3. 6% for Honeywell International Inc. (HON). Over 10 years, the gap is even starker: ROK returned +347. 3% versus HON's +134. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EMR or HON or ROK?
By beta (market sensitivity over 5 years), Honeywell International Inc.
(HON) is the lower-risk stock at 0. 74β versus Emerson Electric Co. 's 1. 52β — meaning EMR is approximately 105% more volatile than HON relative to the S&P 500. On balance sheet safety, Emerson Electric Co. (EMR) carries a lower debt/equity ratio of 68% versus 2% for Honeywell International Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — EMR or HON or ROK?
By revenue growth (latest reported year), Honeywell International Inc.
(HON) is pulling ahead at 7. 8% versus 1. 0% for Rockwell Automation, Inc. (ROK). On earnings-per-share growth, the picture is similar: Emerson Electric Co. grew EPS 17. 8% year-over-year, compared to -15. 5% for Honeywell International Inc.. Over a 3-year CAGR, EMR leads at 9. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EMR or HON or ROK?
Emerson Electric Co.
(EMR) is the more profitable company, earning 12. 7% net margin versus 10. 4% for Rockwell Automation, Inc. — meaning it keeps 12. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EMR leads at 19. 6% versus 17. 1% for ROK. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EMR or HON or ROK more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Emerson Electric Co. (EMR) is the more undervalued stock at a PEG of 5. 04x versus Honeywell International Inc. 's 11. 22x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Honeywell International Inc. (HON) trades at 20. 6x forward P/E versus 37. 8x for Rockwell Automation, Inc. — 17. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HON: 12. 5% to $243. 83.
08Which pays a better dividend — EMR or HON or ROK?
All stocks in this comparison pay dividends.
Honeywell International Inc. (HON) offers the highest yield at 2. 1%, versus 1. 1% for Rockwell Automation, Inc. (ROK).
09Is EMR or HON or ROK better for a retirement portfolio?
For long-horizon retirement investors, Honeywell International Inc.
(HON) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 74), 2. 1% yield, +134. 6% 10Y return). Emerson Electric Co. (EMR) carries a higher beta of 1. 52 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HON: +134. 6%, EMR: +215. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EMR and HON and ROK?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.